高瘤KPNA2表达是晚期神经母细胞瘤患者预后不佳的潜在生物标志物
Sayaka Otake1, Kenjiro Ogushi1, Gendensuren Dorjkhorloo1
1Department of General Surgical Science, Graduate School of Medicine, Gunma University, Maebashi, Japan.
Cancer diagnosis & prognosis
|January 6, 2025
概括
高卡里奥菲林α2 (KPNA2) 表达表明神经母细胞瘤患者的预后较差,特别是那些没有彻底切除瘤的患者. 向KPNA2可能为晚期神经母细胞瘤提供一种新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 卡里奥菲林α2 (KPNA2) 通过促进促进癌症促进蛋白质的核运输,与癌症的攻击性和耐治疗性有关.
- 以前的研究强调了KPNA2在瘤发生和癌症进展中的作用.
- 在神经母细胞瘤中KPNA2表达的临床意义在很大程度上仍未得到研究.
研究的目的:
- 研究神经母细胞瘤患者中KPNA2表达的临床影响和预后价值.
主要方法:
- 免疫组织化学染色用于评估81个神经母细胞瘤组织部分的KPNA2表达.
- 用临床队列和R2数据库分析瘤KPNA2表达的意义和预后价值.
主要成果:
- KPNA2被定位到神经母细胞瘤细胞的核中.
- 核KPNA2表达水平与临床病理因素没有相关性.
- 在81名患者的队列中,高KPNA2表达与非激进切除神经母细胞瘤病例的预后较差相关 (n=37).
- 对大规模神经母细胞瘤队列 (R2数据库) 的分析证实了高KPNA2表达和不良预后之间的关联.
结论:
- KPNA2表达作为神经母细胞瘤的潜在预后指标,特别是在不完全切除的情况下.
- 准KPNA2为高级神经母细胞瘤提供了一个有希望的治疗途径.
更多相关视频
11:12Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
7.8K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.5K
相关概念视频
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Tumor Progression
6.0K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.0K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
